The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement

Objective. Systemic sclerosis (SSc) is a rare, heterogeneous disease, which affects different organs and therefore requires interdisciplinary diagnostic and therapeutic management. To improve the detection and follow-up of patients presenting with different disease manifestations, an interdisciplinary registry was founded with contributions from different subspecialties involved in the care of patients with SSc. Methods. A questionnaire was developed to collect a core set of clinical data to determine the current disease status. Patients were grouped into five descriptive disease subsets, i.e. lcSSc, dcSSc, SSc sine scleroderma, overlap-syndrome and UCTD with scleroderma features. Results. Of the 1483 patients, 45.5% of patients had lcSSc and 32.7% dcSSc. Overlap syndrome was diagnosed in 10.9% of patients, while 8.8% had an undifferentiated form. SSc sine scleroderma was present in 1.5% of patients. Organ involvement was markedly different between subsets; pulmonary fibrosis for instance was significantly more frequent in dcSSc (56.1%) than in overlap syndrome (30.6%) or lcSSc (20.8%). Pulmonary hypertension was more common in dcSSc (18.5%) compared with lcSSc (14.9%), overlap syndrome (8.2%) and undifferentiated disease (4.1%). Musculoskeletal involvement was typical for overlap syndromes (67.6%). A family history of rheumatic disease was reported in 17.2% of patients and was associated with early disease onset (P < 0.005). Conclusion. In this nationwide register, a descriptive classification of patients with disease manifestations characteristic of SSc in five groups allows to include a broader spectrum of patients with features of SSc.

[1]  V. Steen The many faces of scleroderma. , 2008, Rheumatic diseases clinics of North America.

[2]  M. Hudson,et al.  The development of systemic sclerosis classification criteria , 2007, Clinical Rheumatology.

[3]  U. Müller-Ladner,et al.  Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database , 2007, Annals of the rheumatic diseases.

[4]  G. Riemekasten,et al.  [Raynaud phenomenon in dermatology. Part 1: Pathophysiology and diagnostic approach]. , 2006, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[5]  G. Riemekasten,et al.  Raynaud-Phänomen in der Dermatologie , 2006, Der Hautarzt.

[6]  J. Ioannidis,et al.  Mortality in systemic sclerosis: an international meta-analysis of individual patient data. , 2005, The American journal of medicine.

[7]  K. Takehara,et al.  Epidemiological study of patients with systemic sclerosis in Tokyo , 2004, Archives of Dermatological Research.

[8]  Brenda W Gillespie,et al.  Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. , 2003, Arthritis and rheumatism.

[9]  M. Mayes Scleroderma epidemiology. , 2003, Rheumatic diseases clinics of North America.

[10]  S. Bombardieri,et al.  Systemic Sclerosis: Demographic, Clinical, and Serologic Features and Survival in 1,012 Italian Patients , 2002, Medicine.

[11]  U. Haustein Systemic sclerosis-scleroderma. , 2002, Dermatology online journal.

[12]  T. Medsger,et al.  Criteria for the classification of early systemic sclerosis. , 2001, The Journal of rheumatology.

[13]  M. Mayes,et al.  Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. , 2001, Arthritis and rheumatism.

[14]  G. Alarcón Unclassified or undifferentiated connective tissue disease. , 2000, Bailliere's best practice & research. Clinical rheumatology.

[15]  T. Medsger,et al.  Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. , 2000, Arthritis and rheumatism.

[16]  P. Lachenbruch,et al.  The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. , 1998, The Journal of rheumatology.

[17]  T. Medsger,et al.  Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. , 1997, Arthritis and rheumatism.

[18]  A. Silman,et al.  Epidemiology of systemic sclerosis. , 1996, Current opinion in rheumatology.

[19]  Richard W. Martin,et al.  Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. , 1995, The Journal of rheumatology.

[20]  K. Steinsson,et al.  Systemic sclerosis in Iceland. A nationwide epidemiological study. , 1994, Annals of the rheumatic diseases.

[21]  T. Medsger,et al.  Epidemiology and natural history of systemic sclerosis. , 1990, Rheumatic diseases clinics of North America.

[22]  R. Bennett Scleroderma overlap syndromes. , 1990, Rheumatic diseases clinics of North America.

[23]  M. Weinrich,et al.  Prevalence of scleroderma spectrum disorders in the general population of South Carolina. , 1989, Arthritis and rheumatism.

[24]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[25]  M. Vatti,et al.  Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. , 1986, The Journal of rheumatology.

[26]  L. Elveback,et al.  Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. , 1985, Mayo Clinic proceedings.

[27]  H. Hatano [Epidemiology of connective tissue diseases of the skin (scleroderma, dermatomyositis and polymyositis) in Japan]. , 1982, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[28]  A. Masi Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[29]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[30]  H. Maricq,et al.  Undifferentiated connective tissue syndromes. , 1980, Arthritis and rheumatism.

[31]  A. Masi,et al.  Epidemiology of systemic sclerosis (scleroderma). , 1971, Annals of internal medicine.

[32]  G. Rodnan,et al.  Progressive systemic sclerosis sine scleroderma. , 1962, JAMA.